BATON ROUGE, La. (BRPROUD)- Ochsner is enrolling its first participants in the Pfizer COVID-19 vaccine trial on Monday.
Pfizer is beginning its trial on children between the ages 5 and 11.
Ochsner health officials say the trial will have a big impact on reaching herd immunity
“Kids make up approximately a third of our population. You can even argue they circulate more in the community often, more than adults so it’s very important that children be part of the overall push to get heard immunity,” Dr. William Lenarz, the Pediatrics System Chair at Ochsner, said.
Around 70 to 75 children will be able to participate in the trial locally. Around 4500 kids will participate globally.
Dr.Julia Garcia-Diaz, the head of Infectious Disease Clinical Research at Ochsner, said there will be a few differences between this trial and the adult trial.
“The adults was 1:1, which means 50% got the vaccine and 50% got the placebo. This is a 2:1. This means 66% will get the vaccine and only 25% will not,” she said.
The children will be given a different dose than adults.
Participants will be monitored for the next 18 months.
“Our first patient was this morning,” Garcia-Diaz said. “It went quite well, the child was excited to participate.”
Pfizer is the only vaccine approved for children age 12 and older.
Those interested in participating in COVID research can visit here.
The full media briefing with Ochsner is available below.
- Burned St. Landry Parish churches slowly rebuilding
- BRPD identifies person killed in crash on I-12 West
- Police department in Louisiana announces passing of officer while on duty
- Barge stuck on dam causes flooding in Alabama and Mississippi
- Louisiana man arrested after an eventful trip to Academy Sports and Pizza Hut